Position in DHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$205,718
+$950 QoQ
Shares Held
1,080
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1,761
of 2,098 holders
Holding Since
Mar 2022
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NCM Capital Management, LLC holds $420,300 across 2 Diagnostics & Research names. DHR ranks #2 (48.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
428 | $214,582 | |
| 2 | DHR |
Danaher Corp /De/
This page
|
1,080 | $205,718 |
All Filings in DHR
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $205,718 | 1,080 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $204,768 | 1,080 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $249,293 | 1,089 | Shares | Sole | 2026-03-02 | |
| 2025-09-30 | $225,818 | 1,139 | Shares | Sole | 2025-11-14 | |
| 2024-12-31 | $215,547 | 939 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $265,231 | 954 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $238,356 | 954 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $238,232 | 954 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $222,317 | 961 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $249,836 | 1,007 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $254,640 | 1,061 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $266,406 | 1,057 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $276,833 | 1,043 | Shares | Sole | 2023-02-15 | |
| 2022-03-31 | $203,277 | 693 | Shares | Sole | 2022-05-12 | |
| No filing history on record for this holder in this stock. | ||||||